← Evidence map

ArticleMolecular biotechnology2026

Investigating the Efficacy of the CRISPR/Cas9 Gene-Editing System for Targeting the HBB FSC 36-37 (-T) Mutation Locus in Hematopoietic Stem Cells.

Nasim Mayeli Fereydani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026

this papercites it

Investigating the Efficacy of the CRISPR/Cas9 Gene-Editing System for Targeting the HBB FSC 36-37 (-T) Mutation Locus in Hematopoietic Stem Cells. | OpenQuestion